Status:
RECRUITING
Assessment of the Effectiveness of the Metabolomic Approach in Screening for Endometrial Cancer
Lead Sponsor:
National Cancer Institute, Naples
Conditions:
Endometrial Carcinoma (EC)
Eligibility:
FEMALE
50-80 years
Brief Summary
The study involves the use of reagents or materials for diagnostic assessments that are not commercially available, specifically a metabolomic signature for screening endometrial carcinoma and/or othe...
Detailed Description
The study is structured into several phases, described below: * Recruitment and data collection of patients selected for model training at IRCCS Pascale The study will be conducted on patients attend...
Eligibility Criteria
Inclusion
- Female sex
- Age between 50 and 80 years
- Willingness to participate in the study and signing of the informed consent
- Clinical condition of post-menopause
Exclusion
- Previous hysterectomy
- Hormone replacement therapy
- Immunosuppressive therapy
Key Trial Info
Start Date :
July 6 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
July 1 2025
Estimated Enrollment :
3100 Patients enrolled
Trial Details
Trial ID
NCT06893861
Start Date
July 6 2023
End Date
July 1 2025
Last Update
March 25 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Istituto Nazionale Tumori | "Fondazione Pascale"
Napoli, Italy, 80131